Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie’s disease - Concepedia

Concepedia

Publication | Closed Access

Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie’s disease

23

Citations

16

References

2018

Year

Peter Tsambarlis, Raymond Yong, Laurence A. Levine

International Journal of Impotence Research

PathologyFda ApprovalClostridium Collagenase HistolyticumMedicineLimited Success

References

	Year	Citations

Page 1